What Happened at the 5th Lipid Nanoparticles Development Summit Europe?
The summit delivered a dynamic, forward-looking programme focused on addressing the biggest challenges in LNP development. From achieving precise, extrahepatic targeting to improving safety, scalability and real-world delivery, attendees gained practical insights from leaders across biotech, pharma and academia.
Through interactive debates, hands-on discussions and real-world case studies, participants moved beyond theory and into application. Whether they were optimising formulation, advancing toward the clinic, or exploring next-generation delivery systems, attendees gained the clarity, connections and strategies needed to accelerate progress.
Event Highlights
Debate: Breaking Liver Tropism
Heard from leading experts go head-to-head on whether lipid chemistry, formulation tuning or active targeting will finally unlock clinically viable extrahepatic delivery.
End-to-End Simulation: From Concept to Clinic
Stepped through a real-world LNP development journey, made key decisions across design, CMC and regulatory strategy to understand where programs succeed, or fail.
Tackling Toxicity & Repeat Dosing Head-On
Explored the reality of LNP-induced immune responses, anti-PEG challenges and strategies to enable safer, repeatable dosing in therapeutic settings.
Next-Generation Targeting Beyond the Liver
Discovered cutting-edge approaches to BBB penetration, cell-specific delivery and inhalation-based LNPs designed to reach previously inaccessible tissues.
Inside LNP Design & Intracellular Behaviour
Gained rare insight into how LNPs behave inside cells using advanced imaging and how this translates into improved delivery efficiency.
What was New for 2026?
Stronger Focus on Clinical Translation
Greater emphasis on linking LNP design decisions to clinical outcomes, regulatory expectations and commercial viability.
New Debate & Simulation Sessions
Interactive formats including a live debate on breaking liver tropism and an end-to-end clinical simulation exercise.
Expanded Coverage of Toxicity & Repeat Dosing
Dedicated sessions addressing safety, immunogenicity and durability – topics often underrepresented but critical to success.
Introduction of End-User Perspectives
New session highlighting how researchers are applying LNPs in real therapeutic settings and where current systems fall short.
More Global & Diverse Speaker Faculty
Increased representation from emerging biotechs, international academia and cross-functional experts.
Explore the Previous Event Guide
- Get a clear, at-a-glance view of the previous agenda, themes and speaker line-up
- Identify the sessions that would have been most relevant to your work and key LNP challenges
- Explore how leading companies were tackling delivery, targeting and scalability
- Discover the interactive sessions, debates and networking opportunities the summit provided
- Easily share with colleagues to align on future attendance and priorities
Attending Companies Included
Explore the Agenda
Dive into cutting-edge LNP innovation across targeting, delivery, CMC and clinical translation through expert-led talks, interactive debates and practical case studies.
Partner With Us
Position your solutions at the forefront of LNP development and connect with biotech and pharma leaders actively advancing next-generation RNA and gene therapies.
Join LNP Leaders
Engage with a highly focused community of LNP experts across discovery, formulation and manufacturing, and build meaningful connections during dedicated networking sessions.